Bio Techne | TECH - 净收入



金融业
股票价格
USD
资产
USD 2.59B
现金及等价物
USD 264.71M
销售成本
USD 103.13M
流动资产
USD 744.4M
流动负债
USD 163.7M
债务
USD 200M
股息收益率
0.61
EBIT
USD 75.5M
EBITDA
USD 115.94M
员工
3.1K
EPS每股收益
USD 0.52
股本和储备
USD 2.11B
销售毛利
USD 222.15M
债务利息支出
USD 3.6M
利息收入
USD 981K
贷款资金
USD 200M
市值
USD 11.36B
净收入
USD 51.05M
营业费用
USD 235.92M
营业利润
USD 75.5M
普通股股本
USD 156.45M
PE价格收益
38.75
税前利润
USD 106.09M
销售收入
USD 321.2M
销售和管理费用
USD 109.34M
股票
USD 195.74M
贸易债权人
USD 26.7M
应收帐款人
USD 214.56M


净收入 更改 日
Agilent USD 362M 23M 2026-06
Becton, Dickinson and Co. USD 377M 688M 2026-06
Bio Techne USD 51.05M 13.04M 2026-03
Bio-Rad Laboratories USD 371.4M 898.5M 2026-06
Bruker USD -62.9M 66.4M 2026-06
Charles River Laboratories USD -1.48M 13.36M 2026-06
Danaher USD 870M 159M 2026-06
Illumina USD 207M 73M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Merck EUR 490M 169M 2026-06
Mettler Toledo International USD 232.9M 63.44M 2026-06
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Repligen USD 5.01M 3.32M 2026-06
Revvity USD 51.82M 11.1M 2026-06
Standard Biotools USD 127.07M 107.78M 2026-03
Thermo Fisher Scientific USD 1.74B 85M 2026-06
Waters USD -136M 64M 2026-06